GL1X · GenesisL1 explorer

MolNFT v1 · #161075 · protein

Crystal structure of human ror gamma lbd in complex with a quinoline sulfonamide inverse agonist

6Q2W · Nuclear receptor ror-gamma: “Crystal structure of human ror gamma lbd in complex with a quinoline sulfonamide inverse agonist”. X-ray diffraction, 1 ligand (HBW), 8 pockets (best druggability 0.84). MolNFT v1 #161075 on GenesisL1…

PDB
6Q2W
Type
protein
Length
441 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor ror-gamma
UniProt
P51449
Ligands
HBW
Pockets
8 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 71% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor ror-gammaprotein22171% helix, 5% strandP51449
BNuclear receptor ror-gammaprotein22070% helix, 5% strandP51449

Ligands and binding sites

  • HBW · (2~{S})-1-[2,4-bis(chloranyl)-3-[[4-imidazol-1-yl-2-(trifluoromethyl)quinolin-8-yl]oxymethyl]phenyl]sulfonyl-~{N}-methyl-pyrrolidine-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14340.840.9140HBW
24100.840.9141HBW
31300.520.8122empty
4690.500.8517empty
51090.470.8019empty

Interfaces

1 interface between chains.

  • A–B · 1197 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 6Q2W · Crystal structure of human ROR gamma LBD in complex with a quinoline sulfonamide inverse… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.